KYLE DOTSON, O.D.
Optometrist in TOPEKA, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: KYLE DOTSON, O.D. reported a CMS MIPS final score of 93.3967 out of 100, above the 83.1 national average, and filed 1,031 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
KYLE DOTSON, O.D. at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Kansas
How Optometrist compares to other specialties among Kansas providers
Optometrist share within Kansas
Optometrist is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KYLE DOTSON, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 93.3967/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 93.3967/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Optometrist US NPIs
93.3967/100 MIPS final score — 10.3 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 86.7933.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KYLE DOTSON, O.D. is a Optometrist provider practicing in TOPEKA, Kansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1174515985. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
KYLE DOTSON, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 2211 SE 29TH ST, TOPEKA, KS, 66605, with a listed phone of (785) 266-3240. NPI 1174515985 was issued on 08/17/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DOTSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,031 prescription claims written by this provider, covering 211 Medicare beneficiaries and totaling roughly $93K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.3967/100 for the 2023 performance year (Quality 86.7933), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174515985 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 08/17/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KYLE DOTSON, O.D.'s current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 1,031 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,970
- Total Day Supply
- 56,830
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $74K
- Generic Drug Cost
- $20K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 77.2 years
- Avg HCC Risk Score
- 1.15
- Gender Split
- 65% female / 35% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 352 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 222 |
| Brimonidine Tartrate | 65 |
| Timolol Maleate | 43 |
| Dorzolamide Hcl | 38 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 28 |
| Prednisolone Acetate | 28 |
| Lumigan Bimatoprost | 24 |
| Rhopressa Netarsudil Mesylate | 24 |
| Simbrinza Brinzolamide/Brimonidine Tart | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How KYLE DOTSON, O.D. fits within the Optometrist landscape nationally.
KYLE DOTSON, O.D.'s 1,031 claims are above the specialty average of 257.
Nearby Optometrist Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as DOTSON.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is KYLE DOTSON, O.D.'s specialty? ▼
How much does KYLE DOTSON, O.D. prescribe under Medicare Part D? ▼
What is KYLE DOTSON, O.D.'s Medicare quality score? ▼
Where is KYLE DOTSON, O.D. located? ▼
What is KYLE DOTSON, O.D.'s NPI number? ▼
Does KYLE DOTSON, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does KYLE DOTSON, O.D. prescribe most often? ▼
Does KYLE DOTSON, O.D. accept Medicare? ▼
How can I verify KYLE DOTSON, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology